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Abstract
Background: Alterations in the feet of patients with rheumatoid arthritis (RA) are a cause of
disability in this population. The purpose of this research was to evaluate the impact that foot
impairment has on the patients' global quality of life (QOL) based on validated scales and its
relationship to disease activity.
Methods:  This was a cross-sectional study in which 95 patients with RA were enrolled. A
complete physical examination, including a full foot assessment, was done. The Spanish versions of
the Health Assessment Questionnaire (HAQ) Disability Index and of the Disease Activity Score
(DAS 28) were administered. A logistic regression model was used to analyze data and obtain
adjusted odds ratios (AORs).
Results: Foot deformities were observed in 78 (82%) of the patients; hallux valgus (65%), medial
longitudinal arch flattening (42%), claw toe (lesser toes) (39%), dorsiflexion restriction (tibiotalar)
(34%), cock-up toe (lesser toes) (25%), and transverse arch flattening (25%) were the most
frequent. In the logistic regression analysis (adjusted for age, gender and duration of disease),
forefoot movement pain, subtalar movement pain, tibiotalar movement pain and plantarflexion
restriction (tibiotalar) were strongly associated with disease activity and disability. The positive
squeeze test was significantly associated with disability risk (AOR = 6,3; 95% CI, 1.28–30.96; P =
0,02); hallux valgus, and dorsiflexion restriction (tibiotalar) were associated with disease activity.
Conclusion: Foot abnormalities are associated with active joint disease and disability in RA. Foot
examinations provide complementary information related to the disability as an indirect
measurement of quality of life and activity of disease in daily practice.
Background
The estimated incidence of foot impairment in rheuma-
toid arthritis (RA) varies between 85 – 91%. RA foot
impairment mainly affects the forefoot and is the first
symptom of the disease in 15% of RA patients. Symptoms
begin in the metatarsophalangeal joints in nearly 90% of
the cases [1,2]. The chronic synovial inflammation results
in a secondary capsular distension, attrition of the collat-
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eral ligaments, and plantar fascia laxity, thus leading to
subluxation and dislocation of the metatarsophalangeal
joints and the characteristic deformities seen in feet in a
situation of advanced RA [1]: hallux valgus, hammertoe,
claw toe, mallet toe, as well as plantar and dorsal hyperk-
eratosis [3-7].
RA also involves the ankle and hindfoot joints in 30–60%
of the patients. The midfoot itself is not commonly
affected. However, the first metatarsocuneiform joint is
the one that is often affected and consequently causes
instability of the midfoot [1]. Extra-articular compromise
due to severe RA may also be observed in the foot in the
form of bursitis, tendinitis, tenosynovitis, fasciitis, neu-
ropathy, skin ulceration and rheumatoid nodules [8].
RA is a disease that results in serious disability which, in
turn, lowers the quality of life (QOL), increases comor-
bidity, causes a high economic burden and even prema-
ture mortality [9]. There are few studies showing the
impact of rheumatoid foot on the patients' QOL [10].
Rheumatoid foot involvement as well as the failure to pre-
vent or detect their progression early enough might have
a significant impact on the patients' QOL. Thus, we
sought to determine the main foot alterations in RA
patients and to measure the impact of foot impairment on
global QOL based on validated scales and their relation-
ship to disease activity.
Methods
Study design and subjects
This was a cross-sectional study of 95 RA patients attend-
ing the Clinical Immunology and Rheumatology Unit of
the "Clinica Universitaria Bolivariana-Corporación para
Investigaciones Biológicas" in Medellin; all of them met
the required American College of Rheumatology classifi-
cation criteria [11]. Patients were between 18 and 80 years
of age. This study was carried out between December 2005
and March 2007 in compliance with the 1993 regulation
008430 of the Ministry of Health of the Republic of
Colombia. The institutional review board of the "Corpo-
ración para Investigaciones Biológicas" approved the
study design, and written informed consent was received
from all patients.
Foot examination
Feet were evaluated through a detailed clinical and func-
tional examination by two independent and experienced
examiners (a foot and ankle orthopaedic surgeon and an
experienced rheumatologist). The presence or absence of
specific alterations, based on internationally validated
definitions, was recorded on a specific standard data col-
lection form created and agreed upon by the examiners.
Definitions are as follow: hallux valgus: a static subluxa-
tion (significant structural joint displacement without
total luxation) of the first metatarsophalangeal joint char-
acterized by lateral deviation of the big toe and medial
deviation of the first metatarsal [4]; hallux rigidus: a pain-
ful condition of the metatarsophalangeal joint of the big
toe characterized by restricted motion (mainly dorsiflex-
ion) and proliferative periarticular bone formation [12];
hammertoe: a flexion deformity at the proximal inter-
phalangeal joint in which the metatarsalphalangeal joint
is dorsiflexed, and the distal interphalangeal joint is in a
neutral or hyperextended position [6]; claw toe: a dorsi-
flexion deformity of the metatarsophalangeal joint and
flexion deformities at the interphalangeal joints [13]; mal-
let toe: a condition where the distal phalanx is flexed at
the middle phalanx (with involvement of the distal inter-
phalangeal joint) [5]; cock-up toe: an upward displace-
ment of the toes [3]; metatarsophalangeal luxation (both
partial and total): significant structural joint displacement
with or without total luxation [13]; flat foot: a condition
in which the arch of the foot breaks down, thus allowing
the entire sole to touch the ground [14]; transverse arch
flattening: transverse arch foot declination with protru-
sion of the metatarsal heads [15]; dorsal or plantar hyper-
keratosis: well-circumscribed, painful lesions known as
callosities; plantar or dorsal skin ulcers: localized injury to
the skin and/or underlying tissue over a bony prominence
[16]; hindfoot varus [17] and hindfoot valgus [18]; poste-
rior tibial disfunction: evidence of a clinically apparent
flatfoot upon physical examination, showing weakness
with inversion of the plantarflexed foot and an inability to
raise the heel while standing on a single leg [19]. Addi-
tional definitions based on pain follow: on metatarsal
compression: when lateral compression was applied to
the metatarsophalangeal joints in the positive squeeze test
[20,21]; during movements of the forefoot [22]; during
subtalar movements [23]; in tibiotalar movements [23].
Restrictions of the following were also reported: hallux
plantarflexion [4]; hallux dorsiflexion[4]; lesser toes
plantarflexion [5]; lesser toes dorsiflexion [5]; eversion
[24]; inversion [24]; tibiotalar plantarflexion [23]; tibiota-
lar dorsiflexion [23].
Clinical Variables
Besides foot examinations, all patients underwent a
detailed rheumatologic examination; data were recorded
on a specifically created standard data collection form.
Disease activity was defined based on Disease Activity
Score 28 (DAS 28). Patients with a DAS 28 score ≥ 3.2
were considered to have an active disease [25]. Assess-
ment of QOL was based on the Spanish version of the
Health Assessment Questionnaire Disability Index (Span-
ish HAQ-DI) [26] administered the same day as the foot
examination, in addition the patients' global assessment
of disease activity, a physician's global assessment of dis-
ease activity, and a visual analog scale for pain. Laboratory
tests were evaluated and each of the following was classi-BMC Musculoskeletal Disorders 2009, 10:67 http://www.biomedcentral.com/1471-2474/10/67
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fied as positive or negative: high (≥ 28 mm/h) erythrocyte
sedimentation rate (ESR), and high (≥ 0.5 mg/dL) C reac-
tive protein (CRP) serum levels. The rheumatoid factor
(RF) was measured by turbidimetry (Beckman, Brea, CA);
titers >40 U/ml were considered positive [27]. Third gen-
eration anticyclic citrullinated peptide (anti-CCP3) anti-
bodies were measured by using an ELISA kit (QUANTA-
Lite, INOVA, San Diego, CA) and following the manufac-
turer's protocol; titers >60 U were considered positive
[28].
Statistical analysis
Statistical analyses were done using the SPSS statistical
package version 15 (SPSS Institute, Chicago). Associations
between foot deformities, disease activity, and disability
were assessed by means of a univariate analysis using X2
test or Fisher's exact tests when the factors were dichoto-
mous; or t-tests were utilized for assessing mean differ-
ences when the factors were continuous (data not shown).
Then, two stepwise logistic regression models adjusting
for age, gender and duration of disease were applied. DAS
28 >3.2 (Defining active disease) and HAQ (II–III Class
defining high disability score) were used as dependent
variables in the two models. As independent variables, the
models included all the specific foot alterations recorded
in the foot examinations which were significantly associ-
ated with disease activity or disability in univariate analy-
ses. Adjusted odds ratios (AOR) were expressed with their
95% confidence intervals (CI). The level of significance
was defined as p-value < 0.05. Patients who had under-
gone previous foot surgery were excluded in order to
lower the probability of a type II error (β) of accepting a
null hypothesis from a lack of association between
deformities (surgically repaired) and activity and disabil-
ity.
Results
The main demographic and clinical characteristics of the
95 patients included in this study are shown in Table 1.
Foot anomalies were observed in 78 (82%) of them. Hal-
lux valgus (65%), medial longitudinal arch flattening
(42%), claw toe (lesser toes) (39%), dorsiflexion restric-
tion (tibiotalar) (34%), cock-up toe (lesser toes) (35%),
and transverse arch flattening (25%) were the most fre-
quent. The most common foot abnormalities observed
are shown in Table 2. In the logistic regression analysis
adjusted for current age, gender, and duration of disease,
forefoot movement pain was strongly associated with dis-
ease activity (AOR = 14.4; 95% CI, 1.6 – 133.2; P <
0,0001) and disability (AOR = 16.6; 95% CI, 4 – 69.3; P <
0,0001). Pain from subtalar movement, tibiotalar move-
ment, and plantarflexion restriction (tibiotalar) were
associated with disease activity and disability. The positive
squeeze test was significantly associated with disability
risk (AOR = 6.3; 95% CI, 1.3 – 31; P = 0,023). Hallux val-
gus and dorsiflexion restriction (tibiotalar) were associ-
ated with disease activity (Table 3).
Discussion
This study describes the main types of foot impairment in
Northwestern Colombian RA patients and shows their
association with disease activity and disability. Our study
confirms a high rate of rheumatoid foot alterations (82%)
in the patients studied herein. These results are compara-
ble to other reports previously published [1,29].
Foot pain and secondary limitations on regular daily
activities are common complaints of rheumatoid patients.
However, physical examination of the foot may be omit-
ted in routine practice. This lack of examination may be
due to a reliance on the common measurement of disease
activity (DAS28) that omits the feet and ankle joints.
Some authors have found discrepancies in the physical
examination, depending on whether foot and ankle joints
are included in the examination or not, which suggests
that DAS28 should be used cautiously in clinical practice
when disease remission is measured [30].
Despite the fact that examination of the feet has been
omitted from the evaluation of disease activity in RA
patients, we recommend its use. It is an important tool for
predicting disability, which is also the main predictor of
poor outcome in RA patients [31]. In fact, we have shown
Table 1: Main Demographic and clinical characteristics in 95 RA 
patients
Variables Percentage
Female 83.1% (79)
RF (+) 70.1% (63/89)
Steroid therapy 72.6% (69)
Methotrexate 80% (76)
Chloroquine 63.1% (60)
DMARDS 35.7% (34)
Tumor necrosis factor alpha inhibitor 15.8% (15)
Mean ± SD
Current Age (years) 52.5 ± 12.4
Age at RA onset (years) 44 ± 12.4
Duration of RA (years) 9 ± 7.1
Swollen joints count 4.9 ± 5.6
Patient global assessment (VAS) 4.2 ± 2.7
Physician global assessment (VAS) 4.5 ± 2.3
HAQ 0.5 ± 0.6
DAS 28 3.7 ± 1.5
ESR (mm/hour) 30.6 ± 21.1
CRP (mg/dl) 0.9 ± 1.1
RF: rheumatoid factor (IU/ml); HAQ: Health Assessment 
Questionnaire; DAS 28: Disease Activity Score 28; ESR: erythrocyte 
sedimentation rate; CRP: C reactive protein; VAS: Visual Analogue 
Scale; DMARDS: Disease Modifying antirheumatic drugsBMC Musculoskeletal Disorders 2009, 10:67 http://www.biomedcentral.com/1471-2474/10/67
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that some rheumatoid alterations, particularly the ones
related to pain during foot examination, are strongly
related to disease activity as well as to high HAQ scores,
disclosing a strong relationship to disability and QOL.
Although some authors suggest that disease duration does
not necessarily correlate with self-reported foot pain or
disability [32], in this study, we searched for main predic-
tors of high HAQ scores among those with rheumatoid
foot abnormalities. At the same time we adjusted for dis-
ease duration, to avoid bias. It must be recognized that
disease duration increases the correlation between dam-
age and disability [31].
Some disease-related components can be measured by
using a single RA-specific foot-health instrument and sev-
eral generic ones. A number of researchers have developed
a foot impact scale to assess foot status in RA [33].
Another, the Foot Function Index (FFI), was developed to
measure the impact of foot pathology in terms of pain,
Table 2: Main foot abnormalities in a group of 95 patients with RA
Foot Alterations (N = 78) %N
Hallux Valgus 65.3 (62)
Hallux Rigidus 2.1 (2)
Hammer toe (Hallux) 0( 0 )
Hammer toe (Lesser toes) 6.3 (6)
Claw toe (Hallux) 0( 0 )
Claw toe (Lesser toes) 38.9 (37)
Cock-up toe (Hallux) 1.1 (1)
Cock-up toe (Lesser toes) 34.7 (33)
Metatarsofalangeal (luxation) 7.3 (7)
Medial Longitudinal Arch Flattening 42.1 (40/93)
Transverse Arch Flattening 25.3 (24/93)
Plantar/Dorsal Hyperqueratosis 76.8 (73)
Plantar/Dorsal Ulcers 0( 0 )
Hindfoot Valgus 21.1 (20/94)
Hindfoot Varus 17.9 (17/94)
Posterior Tibial Disfunction 2.1 (2/94)
Painful metatarsophalangeal compression positive squeeze test 46.3 (44)
Forefoot movement pain 15.8 (15)
Subtalar movement pain 22.1 (21)
Tibiotalar movement pain 24.2 (23)
Plantarflexion restriction (Hallux) 3.2 (3)
Plantarflexion restriction (Lesser toes) 3.2 (3)
Dorsiflexion restriction (Hallux) 3.2 (3)
Dorsiflexion restriction (Lesser toes) 2.1 (2)
Eversion restriction 26.3 (25)
Inversion restriction 17.9 (17)
Plantarflexion restriction (Tibiotalar) 18.9 (18)
Dorsiflexion restriction (Tibiotalar) 33.7 (32)
Table 3: Foot alterations associated with disability and disease activity risk.
Foot Deformities and Alterations Disease Activity (DAS28 > 3.2) Disability (HAQ II – III)
AOR 95%CI P AOR 95%CI p
Hallux Valgus 2.7 (1–7) 0.018 NS NS NS
Positive Squeeze test NS NS NS 6.3 (1.3 – 31) 0,023
Forefoot movement pain 14.4 (1.6 – 133.2) 0,000 16.6 (4 – 69.3) 0,000
Subtalar movement pain 7.2 (1.6 – 34) 0,012 5.5 (1.5 – 20.5) 0,011
Tibiotalar movement pain 7.9 (1.7 – 37) 0.009 4.7 (1.3 – 17.4) 0.019
Plantarflexion restriction (Tibiotalar) 14 (1.7 – 116.1) 0.014 4.5 (1.2 – 17.1) 0.025
Dorsiflexion restriction (Tibiotalar) 4.7 (1.6 – 14.7) 0.008 NS NS NS
AOR: Adjusted odds ratio by age, gender and duration of disease; CI: confidence interval; DAS 28: Disease Activity Score 28; HAQ: Health 
assessment questionnaireBMC Musculoskeletal Disorders 2009, 10:67 http://www.biomedcentral.com/1471-2474/10/67
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disability and restriction [34]. For FFI and subscales, HAQ
has been the most important predictor [10]. Other studies
have found that moderate-to-high foot impairment and
related disability can be detected early in RA patients [35].
Based on our results, this should encourage performing a
basic physical examination of the feet from the onset of
the disease and during all aspects of medical care in RA
patients because it might be possible to predict disability
based on certain foot alterations.
One of the most interesting results of the present study is
the strong association between the painful compression
metatarsophalangeal positive squeeze test and HAQ disa-
bility. A previous study [36] developed a clinical model
for the prediction, during the first visit, of 3 forms of the
outcome of arthritis: self-limiting, persistent nonerosive,
and persistent erosive. Bilateral compression pain in the
metatarsophalangeal joints (positive squeeze test) is one
of the predictors of persistent erosive arthritis in the
model. At present, we can confirm that it is a predictor of
not only poor outcome but also disability. It is important
to discern that the results reported on the HAQ affect the
QOL significantly and independently [37] and in fact, the
baseline HAQ score was the best predictive factor for QOL
as assessed by the Arthritis Impact Measurement Scales 2
that measures QOL in previous studies [38].
Among the specific foot deformities studied, hallux valgus
was the most prevalent one significantly associated with
disease activity. Some studies based on the use of x-ray
definition revealed a correlation between hallux valgus
and disease severity and at the same time, other deformi-
ties [39]. X-ray classification was not used in the current
study to describe hallux valgus, but it could be imple-
mented for a more exact approach to this deformity. Even
if an X-ray measurement is lacking, it is important to
emphasize the usefulness of evaluating this deformity in
some way in daily practice because it is associated with a
high DAS28 score. It is of interest to mention that when
some authors measured hallux valgus using X-rays, the
results were comparable to the judgment of a panel of
experienced clinicians [40].
A significant association between tibiotalar movement
pain, plantarflexion restriction (tibiotalar), dorsiflexion
restriction (tibiotalar) and disease activity was found. This
anatomical region is not easy to examine; this association
could be related to the presence of existing inflammation
(i.e., pannus and synovitis) that is not always easily found
during clinical examination. In fact some authors have
found poor ranges for sensitivity (55–83%), and specifi-
city (23–46%) while looking for tibiotalar synovitis by
comparing clinical examination and ultrasound with
magnetic resonance imaging as a gold standard method
[41].
Conclusion
This is the first study evaluating foot impairment in this
particular population of patients with RA. Foot abnormal-
ities are associated with active joint disease and disability
in this population. It is important to notice that pain
score, one of the components of DAS28, is the predomi-
nant clinical assessment associated with poor health sta-
tus, which is measured by using disability and QOL
instruments [31]. It also has the greatest impact on indi-
vidual subdimensions of the HAQ as a measure of disabil-
ity [42]. Foot examinations in daily practice provide
complementary information related to the disability as an
indirect measurement of QOL and activity of the disease
and should be systematically included to complement but
not replace any of the existing measuring tools. This study
should guide future research in the search for an associa-
tion between corrected foot deformities under conserva-
tive (i.e., orthoses) or surgical treatment and disease
activity and disability in a longitudinal design, encourag-
ing the inclusion of a higher sample size that should have
a strong statistical association with rheumatoid foot
impairment.
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